Company profile · Vilnius, Lithuania

LT Biotech

In-Vitro Diagnostics, Cell Culture Media, Protein Purification Materials, and Bioprocess Support · Bioprocess and diagnostic-supply platform for research and industrial users

Verified 21 Mar 2026 · 2 sources

DiagnosticsCommercial

LT Biotech enters the Lithuania layer with an official CEO disclosure inside its own conformity documentation, a source-backed Vilnius manufacturing address, and a product mix centered on diagnostics and bioprocess…

Lead
Pavel Karabliov (verified ↗)
Compliance
CE registration number LT/CA01/IVD/002/21 · ISO 9001:2015 quality management reference
Last reviewed
21 Mar 2026 (3mo ago)
Scale
Bioprocess and diagnostic-supply platform for research and industrial users
Capabilities
In-Vitro Diagnostic Kit Development · Cell Culture Media and Sera Supply · Protein Purification Materials
Founded
2015
Headcount
1-10
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Pavel Karabliov

Chief Executive Officer

Check official leadership source
Full addressMokslininku g. 6A, LT-08412 Vilnius, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official LT Biotech contacts page listing the Mokslininku 6A Vilnius address.

Open source
Operating profile

Bioprocess and diagnostic-supply platform for research and industrial users

Vilnius, Lithuania. In-Vitro Diagnostics, Cell Culture Media, Protein Purification Materials, and Bioprocess Support. Review completed on 21 Mar 2026.

2026 technical specializationIn-Vitro Diagnostics, Cell Culture Media, Protein Purification Materials, and Bioprocess Support
Core capabilities
In-Vitro Diagnostic Kit DevelopmentCell Culture Media and Sera SupplyProtein Purification Materials
Governance

State Health Care Accreditation Agency under the Ministry of Health of Lithuania and EU IVD oversight

CE registration number LT/CA01/IVD/002/21, Directive 98/79/EC IVD conformity declaration, ISO 9001:2015 quality management reference

Editorial note

In-Vitro Diagnostics, Cell Culture Media, Protein Purification Materials, and Bioprocess Support

LT Biotech enters the Lithuania layer with an official CEO disclosure inside its own conformity documentation, a source-backed Vilnius manufacturing address, and a product mix centered on diagnostics and bioprocess materials.

Editorial note

LT Biotech enters the Lithuania layer with an official CEO disclosure inside its own conformity documentation, a source-backed Vilnius manufacturing address, and a product mix centered on diagnostics and bioprocess materials.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 21 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

In-Vitro Diagnostic Kit Development
Cell Culture Media and Sera Supply
Protein Purification Materials
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial LT Biotech declaration-of-conformity PDF naming Pavel Karabliov as CEO.Source origin: ltbiotech.ltOpen source
Supporting evidenceOfficial LT Biotech contacts page listing the Mokslininku 6A operating address in Vilnius.Source origin: ltbiotech.ltOpen source
Physical-site evidenceOfficial LT Biotech contacts page listing the Mokslininku 6A Vilnius address.Source origin: ltbiotech.ltOpen source
Infrastructure

Declared infrastructure

Diagnostic-kit development workflows
Cell-culture media manufacturing systems
Protein purification and chromatography product line
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is LT Biotech located?
LT Biotech operates from Mokslininku g. 6A, LT-08412 Vilnius, Lithuania, Vilnius, Lithuania.
Who runs LT Biotech?
LT Biotech is led by Pavel Karabliov, Chief Executive Officer. Verified 21 Mar 2026.
What certifications does LT Biotech hold?
LT Biotech is documented under CE registration number LT/CA01/IVD/002/21, ISO 9001:2015 quality management reference.
What does LT Biotech do?
LT Biotech enters the Lithuania layer with an official CEO disclosure inside its own conformity documentation, a source-backed Vilnius manufacturing address, and a product mix centered on diagnostics and bioprocess… Core capabilities: In-Vitro Diagnostic Kit Development, Cell Culture Media and Sera Supply, Protein Purification Materials.
Editorial context

Related technical briefs

Briefs that name Vilnius as a covered market or city.